165 related articles for article (PubMed ID: 37900425)
21. Lack of association between dental implants and oral squamous cell carcinoma.
Afrashtehfar KI; Almomani MM; Momani M
Evid Based Dent; 2022 Mar; 23(1):40-42. PubMed ID: 35338331
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical Evaluation of GLUT-3 and GLUT-4 in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Feitosa SG; Viana KF; Luna ECM; Costa FWG; Cavalcante RB; Chaves FN; Chaves HV; Pereira KMA
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1779-1783. PubMed ID: 30049187
[TBL] [Abstract][Full Text] [Related]
23. Expression of Glut-1 is a prognostic marker for oral squamous cell carcinoma patients.
Eckert AW; Lautner MH; Taubert H; Schubert J; Bilkenroth U
Oncol Rep; 2008 Dec; 20(6):1381-5. PubMed ID: 19020718
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA Profiling in Circulating Exosomes in Oral Squamous Cell Carcinoma: A Systematic Review.
Y D; Ramani P; Yuwanati M; Ramalingam K; S G
Cureus; 2023 Aug; 15(8):e43235. PubMed ID: 37692575
[TBL] [Abstract][Full Text] [Related]
25. Exosome-derived microRNAs in oral squamous cell carcinomas impact disease prognosis.
Chen CM; Chu TH; Chou CC; Chien CY; Wang JS; Huang CC
Oral Oncol; 2021 Sep; 120():105402. PubMed ID: 34174519
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-155 in oral squamous cell carcinoma: Overexpression, localization, and prognostic potential.
Shi LJ; Zhang CY; Zhou ZT; Ma JY; Liu Y; Bao ZX; Jiang WW
Head Neck; 2015 Jul; 37(7):970-6. PubMed ID: 24692283
[TBL] [Abstract][Full Text] [Related]
28. Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study.
Gholami S; Chamorro-Petronacci C; Pérez-Sayáns M; Suárez Peñaranda J; Longatto-Filho A; Baltazar F; Afonso J
J Appl Oral Sci; 2023; 31():e20220461. PubMed ID: 37194791
[TBL] [Abstract][Full Text] [Related]
29. Predicting the Presence of Oral Squamous Cell Carcinoma Using Commonly Dysregulated MicroRNA in Oral Swirls.
Yap T; Koo K; Cheng L; Vella LJ; Hill AF; Reynolds E; Nastri A; Cirillo N; Seers C; McCullough M
Cancer Prev Res (Phila); 2018 Aug; 11(8):491-502. PubMed ID: 29764807
[TBL] [Abstract][Full Text] [Related]
30. Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?
Grimm M; Cetindis M; Lehmann M; Biegner T; Munz A; Teriete P; Kraut W; Reinert S
J Transl Med; 2014 Jul; 12():208. PubMed ID: 25048361
[TBL] [Abstract][Full Text] [Related]
31. Identification of key miRNAs and targeted genes involved in the progression of oral squamous cell carcinoma.
Gu Y; Tang S; Wang Z; Cai L; Shen Y; Zhou Y
J Dent Sci; 2022 Apr; 17(2):666-676. PubMed ID: 35756810
[TBL] [Abstract][Full Text] [Related]
32. GLUT-1(+)/TKTL1(+) coexpression predicts poor outcome in oral squamous cell carcinoma.
Grimm M; Munz A; Teriete P; Nadtotschi T; Reinert S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):743-53. PubMed ID: 24703406
[TBL] [Abstract][Full Text] [Related]
33. Expression of mRNA for glucose transport proteins in jejunum, liver, kidney and skeletal muscle of pigs.
Aschenbach JR; Steglich K; Gäbel G; Honscha KU
J Physiol Biochem; 2009 Sep; 65(3):251-66. PubMed ID: 20119820
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of facilitative glucose transporters in normal and tumour kidney tissues.
Suganuma N; Segade F; Matsuzu K; Bowden DW
BJU Int; 2007 May; 99(5):1143-9. PubMed ID: 17437443
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of microRNA-218 promotes oral squamous cell carcinoma growth by targeting GLUT1 to affect glucose metabolism.
Xu XJ; Yuan J; Sun WJ; Chen QY; Lin Y; Tang L; Liang LZ
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7726-7734. PubMed ID: 30536316
[TBL] [Abstract][Full Text] [Related]
36. Circle RNA hsa_circRNA_100290 serves as a ceRNA for miR-378a to regulate oral squamous cell carcinoma cells growth via Glucose transporter-1 (GLUT1) and glycolysis.
Chen X; Yu J; Tian H; Shan Z; Liu W; Pan Z; Ren J
J Cell Physiol; 2019 Nov; 234(11):19130-19140. PubMed ID: 31187488
[TBL] [Abstract][Full Text] [Related]
37. Glucose transporter proteins (GLUT) in human endometrium: expression, regulation, and function throughout the menstrual cycle and in early pregnancy.
von Wolff M; Ursel S; Hahn U; Steldinger R; Strowitzki T
J Clin Endocrinol Metab; 2003 Aug; 88(8):3885-92. PubMed ID: 12915684
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the association of OCT3/4 with GLUT1 and CD105 in oral squamous cell carcinoma using dual immunohistochemistry.
Derakhshan S; Mahdavi N; Kardouni Khoozestani N; Nasr Esfahani B; Heidarian F; Rahrotaban S; Abdolrahmani A
BMC Oral Health; 2022 Jul; 22(1):300. PubMed ID: 35854304
[TBL] [Abstract][Full Text] [Related]
39. LncRNA ELF3-AS1 is involved in the regulation of oral squamous cell carcinoma cell proliferation by reprogramming glucose metabolism.
Chu H; Li Z; Gan Z; Yang Z; Wu Z; Rong M
Onco Targets Ther; 2019; 12():6857-6863. PubMed ID: 31686842
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of glucose transporters mediated by CRH receptor type 1 and type 2 in human placental trophoblasts.
Gao L; Lv C; Xu C; Li Y; Cui X; Gu H; Ni X
Endocrinology; 2012 Mar; 153(3):1464-71. PubMed ID: 22234467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
